<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03049163</url>
  </required_header>
  <id_info>
    <org_study_id>KYQD131101-01</org_study_id>
    <nct_id>NCT03049163</nct_id>
  </id_info>
  <brief_title>Comparison the Topical Anesthesia and Retrobulbar Anesthesia for 27-gauge Vitrectomy for Vitreous Floaters</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lin Zhong</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Eye Hospital of Wenzhou Medical University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Routine anesthesia methods for vitrectomy surgery include retrobulbar and peribulbar
      anesthesia. However, both methods have potential complications that can vary from minor to
      severe.

      Vitrectomy surgery for vitreous floaters is widely considered straighter forward than other
      vitreoretinal surgeries.

      Hence, the investigators compared the effect of topical anesthesia (with eye drops) and
      retrobulbar anesthesia for 27-gauge par plana vitrectomy for symptomatic vitreous floaters.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2016</start_date>
  <completion_date type="Anticipated">June 2017</completion_date>
  <primary_completion_date type="Anticipated">March 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual Analogue Pain Scale</measure>
    <time_frame>2 hour post-operation</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Perioperative Pain Experiences</condition>
  <arm_group>
    <arm_group_label>vitrectomy under retrobulbar anesthesia</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>27-gauge vitrectomy for vitreous floaters under traditional retrobulbar anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>vitrectomy under topical anesthesia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>27-gauge vitrectomy for vitreous floaters under topical anesthesia</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>vitrectomy under topical anesthesia [Proparacaine HCL (Alcaine®)]</intervention_name>
    <description>to observe the anesthesia effect of topical anesthesia of 27-gauge vitrectomy for vitreous floaters</description>
    <arm_group_label>vitrectomy under retrobulbar anesthesia</arm_group_label>
    <arm_group_label>vitrectomy under topical anesthesia</arm_group_label>
    <other_name>0.5% proparacaine HCL (Alcaine®, Alcon, TX)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. patients who is going to undergo vitrectomy surgery for vitreous floaters

          2. age&gt;18 years

          3. patients who are willing to participate in this study

        Exclusion Criteria:

          1. patients who had vitrectomy surgery before

          2. patients who had penetrating ocular trauma before
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Zhong Lin, Doctor</last_name>
    <phone>+8613758475525</phone>
  </overall_contact>
  <location>
    <facility>
      <name>Ethics Committee of The Eye Hospital of Wenzhou Medical University</name>
      <address>
        <city>Wenzhou</city>
        <state>Zhejiang</state>
        <zip>325027</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peiqiu Gu, bachelor</last_name>
      <phone>+8613695896445</phone>
      <email>gupeiqiu@126.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 28, 2017</study_first_submitted>
  <study_first_submitted_qc>February 8, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 9, 2017</study_first_posted>
  <last_update_submitted>February 8, 2017</last_update_submitted>
  <last_update_submitted_qc>February 8, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 9, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>The Eye Hospital of Wenzhou Medical University</investigator_affiliation>
    <investigator_full_name>Lin Zhong</investigator_full_name>
    <investigator_title>Resident</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Proxymetacaine</mesh_term>
    <mesh_term>Propoxycaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

